Skip to content
10-Q

Quarterly Report

NantHealth, Inc.

0001566469-23-000028

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 12, 2023 7.7M sh
Shares Diluted Q1 2023 · Mar 31, 2023 7.7M sh
Shares Diluted restated Q1 2023 · Mar 31, 2022 7.7M sh
Capex Q1 2023 · Mar 31, 2023 $1.26M
Capex Q1 2023 · Mar 31, 2022 $1.2M
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$6.57M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$11.05M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $14.15M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $1.76M
Stockholders Equity Q1 2023 · Mar 31, 2023 −$236.65M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$225.39M
Current Liabilities Q1 2023 · Mar 31, 2023 $38.39M
Current Liabilities Q1 2023 · Dec 31, 2022 $35.63M
Total Liabilities Q1 2023 · Mar 31, 2023 $406.15M
Total Liabilities Q1 2023 · Dec 31, 2022 $384.94M
Current Assets Q1 2023 · Mar 31, 2023 $24.71M
Current Assets Q1 2023 · Dec 31, 2022 $12.59M
Total Assets Q1 2023 · Mar 31, 2023 $169.5M
Total Assets Q1 2023 · Dec 31, 2022 $159.55M
Eps Diluted Q1 2023 · Mar 31, 2023 −$1.59
Eps Diluted restated Q1 2023 · Mar 31, 2022 −$2.07
Eps Basic Q1 2023 · Mar 31, 2023 −$1.59
Eps Basic restated Q1 2023 · Mar 31, 2022 −$2.07
Sga Expense Q1 2023 · Mar 31, 2023 $16.71M
Sga Expense Q1 2023 · Mar 31, 2022 $14.98M
Rd Expense Q1 2023 · Mar 31, 2023 $5.16M
Rd Expense Q1 2023 · Mar 31, 2022 $5.72M
Net Income Q1 2023 · Mar 31, 2023 −$12.24M
Net Income Q1 2023 · Mar 31, 2022 −$15.95M
Operating Income Q1 2023 · Mar 31, 2023 −$12.23M
Operating Income Q1 2023 · Mar 31, 2022 −$12.49M
Gross Profit Q1 2023 · Mar 31, 2023 $10.63M
Gross Profit Q1 2023 · Mar 31, 2022 $9.19M
Revenue Q1 2023 · Mar 31, 2023 $17.05M
Revenue Q1 2023 · Mar 31, 2022 $16.37M